Impact of prolonged embryo storage on reproductive and neonatal outcomes: a systematic review and meta-analysis.

Purpose: To analyze the influence of embryo storage on reproductive and neonatal results in patients undergoing in vitro fertilization (IVF) treatment.

Methods: PubMed, Embase, Cochrane Central Register of Controlled Trials, and BioMed Central databases were searched from inception up to June 2024 for studies comparing reproductive and neonatal outcomes in patients undergoing frozen embryo transfer within 12 months from embryo storage versus more than 12 months after embryo storage. Data were pooled by meta-analysis using a random effects model.

Impact of Endometrial Receptivity Analysis on Pregnancy Outcomes In Patients Undergoing Embryo Transfer: A Systematic Review and Meta-Analysis.

To analyze the influence of endometrial receptivity analysis (ERA) on embryo transfer (ET) results in patients undergoing in vitro fertilization (IVF) treatment. PubMed, Embase, Cochrane Central Register of Controlled Trials, and BioMed Central databases were searched from inception up to December 2022 for studies comparing pregnancy outcomes in patients undergoing personalized embryo transfer (pET) by ERA versus standard ET. Data were pooled by meta-analysis using a random effects model.

[Results of the implementation of a protocol of attention to victims of sexual assault in Emergencies of a reference tertiary hospital.].

Objective: To assess the degree of compliance of the Comprehensive Health and Judicial Care Protocol for Victims of Sexual Assaults attended in Emergencies, and to compare the quality indicators of care with those obtained for the 2 years prior to its implementation.

Methods: Retrospective, comparative, cohort study of the 128 victims (124 women and 4 men), aged 4 to 62 years, treated in the Hospital Emergency Department, before and after the publication of the Protocol through the CIE-10 diagnostic code T74.2 Sexual assault and CIE-10 T76.

The RANKL/RANK system in female reproductive organ tumors: A preclinical and clinical overview.

The receptor activator of nuclear factor-κB (RANK) and its ligand RANKL are members of the tumor necrosis factor (TNF) super-family of cytokines with a role in progestogen-associated malignancies in breast. Basic and clinical data support the participation of the cytokine pathway in metastatic disease and as poor prognosis markers. The value of RANK/RANKL as prognostic indicators in endometrial and ovarian tumors, as well as the data suggesting a potential role of RANK/RANKL in hormone dependent tumorigenesis in the endometrium, have been described.